AstraZeneca Partners with CCT to Conduct COVID-19 Vaccine Clinical Trials

CCT Research announced its partnership with AstraZeneca to advance COVID-19 research. Together with local healthcare providers, CCT will facilitate clinical trials for the AZD1222 COVID-19 VACCINE, an investigational vaccine for the prevention of COVID-19.

CCT is recruiting eligible study participants who are 18 years of age or older, not pregnant, in good general health and have not been previously diagnosed with COVID-19.

"CCT is honored to work alongside AstraZeneca amid this unprecedented public health crisis. Our established network and embedded trial design allowed us to quickly and efficiently prepare multiple sites to facilitate high-volume COVID vaccine trials safely," stated CJ Anderson, President of CCT. "Our network approach enables us to provide our sponsor with a stable clinical environment."

"Covid-19 has been and continues to be devastating to our world. Finding a vaccine is one tool that will help us return to our new normal," said Thomas Fiel, D.O., family practice physician and Arizona principal investigator. "I understand the need for clinical trials, as well as the anxiety they can bring to study participants. By conducting this trial through local medical practices like ours, CCT and AstraZeneca can build on an existing foundation of trust, ultimately improving the patient experience. It is another way that, as a community physician, I can help fight this battle."

Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!

The study takes place at Bayless Integrated Healthcare's downtown Phoenix location at 3620 N 3rd St. in Phoenix.

Eligible study participants must be 18 years of age or older, not pregnant, in good general health, and have not been previously diagnosed with COVID-19. Participants are reimbursed for expenses related to the study. This study compares an investigational vaccine against a placebo to see if the vaccine can prevent COVID-19.

  • <<
  • >>

Join the Discussion